Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 8-K Event Material agreement · New debt or obligation
  2. 4 Open-market sale President and CEO sold 4,060 shares at an average $31.75 ($128,910)
  3. 4 Open-market sale President and CEO sold 2,900 shares at $31.79 ($92,199)
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13D/A Stake Beneficial Ownership Report
  6. 4 Open-market sale Chief Scientific Officer sold 16,999 shares at $29.99 ($509,715)
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 4 Open-market sale Chief Technical Officer sold 55,621 shares at an average $30.00 ($1,668,665)
  9. 4 Open-market sale See Remark 1 sold 100,000 shares at an average $29.86 ($2,986,216)
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations · Other events
  12. 4 Open-market sale 10% owner sold 48,600 shares at an average $28.48 ($1,383,988)
  13. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $25.54 ($289,433)
  14. 4 Open-market sale Chief Technical Officer sold 3,991 shares at an average $26.13 ($104,272)
  15. 4 Open-market sale Chief Technical Officer sold 73,741 shares at an average $25.02 ($1,844,735)
  16. 4 Open-market sale Chief Technical Officer sold 43,495 shares at $20.02 ($870,931)
  17. 8-K Event Other events
  18. 4 Option exercise Chief Financial Officer acquired 1,925 shares (option exercise)
  19. 4 Open-market sale Chief Scientific Officer sold 4,250 shares at $16.89 ($71,775)
  20. 8-K Event Other events

Page 36 of 47 · 923 filings